OGN
Organon & Co.
Halal Rating :
See Details
Last Price
$16.31
Last updated:
Market Cap
$5.66b
7D Change
-5.51%
1 Year Change
-32.28%
Company Overview
Industries
Exchange
NYSE
Next Earnings Date
Nov. 2, 2023
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $1.61b | $579m | - | $132m | 0.00% | 22.80% |
| March 31, 2023 | $1.54b | $576m | - | $132m | 0.00% | 22.92% |
| Dec. 31, 2022 | $1.49b | $745m | - | $119m | 0.00% | 15.97% |
Company Impact
Help us evaluate Organon & Co.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.